OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study)
Phase 3
Recruiting
- Conditions
- Primary Membranous Nephropathy
- Interventions
- Drug: Glucocorticoids
- First Posted Date
- 2025-01-17
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 144
- Registration Number
- NCT06781944
- Locations
- 🇨🇳
Huashan Hospital, Fudan University, Shanghai, Shanghai, China
Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery
Phase 2
Not yet recruiting
- Conditions
- Glioblastoma
- Interventions
- Drug: Vebreltinib + Temozolomide
- First Posted Date
- 2025-01-17
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06780592
The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors
Phase 2
Recruiting
- Conditions
- Gastrointestinal Tumors
- Interventions
- Drug: propranolol (beta-blocker used treat high blood pressure)
- First Posted Date
- 2025-01-14
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06775080
- Locations
- 🇨🇳
Huashan Hospital, Fudan University, Shanghai, Shanghai, China
Incremental Dialysis Decision Model Based on Expert-Guided Machine Learning
Completed
- Conditions
- End-stage Renal Disease
- First Posted Date
- 2025-01-14
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 175
- Registration Number
- NCT06775067
- Locations
- 🇨🇳
Huashan hospital, Fudan university, Shanghai, Shanghai, China
Rapid Kidney Function Decline in Older Adults
Completed
- Conditions
- Kidney Function DeclineGlomerular Filtration RateUrine Albumin-creatinine RatioHealthy AgingComorbidityChronic Kidney Disease
- First Posted Date
- 2025-01-09
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 1539
- Registration Number
- NCT06765811
- Locations
- 🇨🇳
Huashan hospital, Fudan university, Shanghai, Shanghai, China
PDO Based Drug Sensitive Test in R/M SGC
Active, not recruiting
- Conditions
- Salivary Gland CancersPatient Derived OrganoidDrug Sensitive Test in Vitro
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06686979
- Locations
- 🇨🇳
Huashan Hospital, Fudan University, Shanghai, Shanghai, China
PDO Based Drug Sensitive Test in R/M HNSCC
Active, not recruiting
- Conditions
- Head and Neck Squamous Cell CarcinomaPatient Derived OrganoidDrug Sensitive Test in Vitro
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06686342
- Locations
- 🇨🇳
Huashan Hospital, Fudan University, Shanghai, Shanghai, China
Application of a New Surgical Technique in Proximal Gastrectomy: a Prospective, Multicenter Randomized Controlled Study
Not Applicable
Recruiting
- Conditions
- Gastric Cancer Patients Undergoing Minimally Invasive Gastrectomy
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 52
- Registration Number
- NCT06679244
- Locations
- 🇨🇳
Huashan Hospital, Fudan University, Shanghai, China
Pre-operative Surgical Difficulty Stratification Using Predicted Tumor Perfusion and Consistency
Active, not recruiting
- Conditions
- Pituitary Adenoma
- First Posted Date
- 2024-10-29
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06664190
- Locations
- 🇨🇳
Huashan Hospital, Shanghai, Shanghai, China
Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort
Phase 3
Recruiting
- Conditions
- Drug-resistant TuberculosisPulmonary TuberculosisRifampin-resistant Tuberculosis
- Interventions
- First Posted Date
- 2024-10-21
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT06649721
- Locations
- 🇨🇳
The Fifth Hospital of Shijiazhuang, Shijiazhuang, Hebei, China
🇨🇳Wenzhou Central Hospital, Wenzhou, Zhejiang, China
🇨🇳Beijing Chest Hospital, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath